Notes from the field: jumpstarting the IRB approval process in multicenter studies
Related Experiment Video
Updated: Jul 13, 2026

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Jan Blustein1, Marsha Regenstein, Bruce Siegel
1Wagner Graduate School, New York University, Puck Building, 295 Lafayette Street, New York, NY 10012, USA.
Objective:
To identify strategies that facilitate readiness for local Institutional Review Board (IRB) review, in multicenter studies.
Study Setting:
Eleven acute care hospitals, as they applied to participate in a foundation-sponsored quality improvement collaborative.
Study Design:
Case series.
Data Collection/Extraction:
Participant observation, supplemented with review of written and oral communications.
Principal Findings:
Applicant hospitals responded positively to efforts to engage them in early planning for the IRB review process. Strategies that were particularly effective were the provisions of application templates, a modular approach to study description, and reliance on conference calls to collectively engage prospective investigators, local IRB members, and the evaluation/national program office teams. Together, these strategies allowed early identification of problems, clarification of intent, and relatively timely completion of the local IRB review process, once hospitals were selected to participate in the learning collaborative.
Conclusions:
Engaging potential collaborators in planning for IRB review may help expedite and facilitate review, without compromising the fairness of the grant-making process or the integrity of human subjects protection.
Related Concept Videos
Bioequivalence studies: Biowaivers
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Preclinical Development: Overview
Bioavailability Study Design: Healthy Subjects Versus Patients

